The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S. Reader, John F. Marshall|The Journal of Pathology|2019Cited by 109
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virusKate M. Moore, John F. Marshall|Theranostics|2020Cited by 49
Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancerNicholas F. Brown, John F. Marshall|Pancreatology|2024Cited by 12
The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocompetent ModelJohn F. Marshall|Cancers|2025Cited by 1